Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  dimerizer drug AP1903
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
AP1903 and Genetically Modified Donor T Cells after Donor Stem Cell Transplant in Treating Patients with Hematologic Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: 2012-0501, NCI-2013-01666, RM00000684-RN00, NCT01875237
Biological Therapy and Gene Therapy in Improving Immune System Recovery After Stem Cell Transplant in Patients With Hematopoietic Cancers
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: Not specified
Trial IDs: DOTTI, NCI-2012-01076, H-28256, NCT01494103
Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BP-PC-002, NCI-2013-01266, NCT01823978
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Phase: Phase I
Type: Supportive care, Treatment
Age: 4 months to 54 years
Trial IDs: BP-003, NCI-2014-02100, NCT02231710
Start Over